benzothiazole has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajiro, M; Alqasem, AA; Clark, B; Hagiwara, M; Iida, K; Ladomery, MR; Li, L; Oltean, S; Perks, CM; Porazinski, SR; Uzor, S; Wilson, ID | 1 |
| Gao, X; Hu, D; Jin, L; Song, B; Xu, R; Yang, S; Zhang, G; Zhang, S | 1 |
2 other study(ies) available for benzothiazole and Prostatic Neoplasms
| Article | Year |
|---|---|
CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer.
Topics: Alternative Splicing; Animals; Apoptosis; Benzothiazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinases; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Mice, Nude; Molecular Targeted Therapy; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Kinase Inhibitors; RNA-Seq; Thiazoles; Xenograft Model Antitumor Assays | 2021 |
Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-alpha-aminophosphonates.
Topics: Antineoplastic Agents; Benzothiazoles; Cell Proliferation; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Melanoma; Organophosphonates; Prohibitins; Prostatic Neoplasms; Skin Neoplasms; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2006 |